Squarepoint
CVS icon

Squarepoint’s CVS Health CVS Stock Holding History

Squarepoint’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
175,900
+127,800
+266% +$11.4M 0.02% 743
2026
Q1 		$3.45M Sell
48,100
-24,200
-33% -$1.86M ﹤0.01% 1776
2025
Q4 		$5.74M Sell
72,300
-2,000
-3% -$158K 0.01% 1374
2025
Q3 		$5.6M Sell
74,300
-196,200
-73% -$13.4M 0.01% 1393
2025
Q2 		$18.7M Sell
270,500
-926,800
-77% -$60.8M 0.02% 797
2025
Q1 		$81.1M Buy
1,197,300
+857,300
+252% +$51.3M 0.1% 205
2024
Q4 		$15.3M Sell
340,000
-217,700
-39% -$12.2M 0.02% 902
2024
Q3 		$35.1M Buy
557,700
+252,500
+83% +$14.7M 0.05% 363
2024
Q2 		$18M Sell
305,200
-517,200
-63% -$32.4M 0.03% 635
2024
Q1 		$65.6M Buy
822,400
+318,500
+63% +$24.3M 0.11% 177
2023
Q4 		$39.8M Buy
503,900
+74,200
+17% +$5.28M 0.08% 296
2023
Q3 		$30M Buy
429,700
+281,600
+190% +$20M 0.07% 299
2023
Q2 		$10.2M Buy
148,100
+3,500
+2% +$249K 0.03% 661
2023
Q1 		$10.7M Buy
144,600
+130,200
+904% +$10.9M 0.04% 509
2022
Q4 		$1.34M Buy
+14,400
New +$1.39M 0.01% 1616
2022
Q2 		– Sell
-94,100
Closed -$9.52M – 2959
2022
Q1 		$9.52M Buy
94,100
+36,400
+63% +$3.82M 0.04% 465
2021
Q4 		$5.95M Buy
57,700
+12,700
+28% +$1.17M 0.02% 723
2021
Q3 		$3.82M Buy
45,000
+35,200
+359% +$2.95M 0.01% 902
2021
Q2 		$818K Sell
9,800
-4,900
-33% -$401K ﹤0.01% 1786
2021
Q1 		$1.11M Sell
14,700
-1,000
-6% -$72.8K 0.01% 1427
2020
Q4 		$1.07M Buy
+15,700
New +$1.02M 0.01% 1282
2019
Q4 		– Sell
-5,700
Closed -$359K – 2526
2019
Q3 		$359K Buy
+5,700
New +$338K ﹤0.01% 1798

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Squarepoint's CVS Position: Q2 2026 in Review

Squarepoint reduced its CVS Health (CVS) stake by 87% in Q2 2026, selling an estimated $35M and leaving 60,741 shares worth $6.28M. The position accounts for 0.01% of the portfolio, ranked #1401.

Squarepoint first reported a position in CVS in Q4 2014 and has held it in 42 quarters since. The position peaked at $156M in Q1 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Squarepoint held 60,741 shares of CVS Health worth $6.28M as of Q2 2026.
  • Squarepoint sold 391,823 CVS Health shares in Q2 2026, an estimated $35M.
  • CVS Health made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1401 holding.
  • Squarepoint first reported a position in CVS Health in Q4 2014 and has held it in 42 quarters since.
  • Squarepoint's CVS Health position peaked at $156M in Q1 2023.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.